Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context
Halimatou Diawara, Jane Grant, Alassane Dicko, Seydou Traore, Djibrilla Issiaka, Fatoumata Koita, Mehreen Datoo, Mala Sylla, Abdrahmane Boncane Dicko, Issaka Sagara, Daniel Chandramohan, Adrian Vs Hill, Brian Greenwood, Jayne Webster
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.